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Lys49 snake-venom phospholipase A2 (PLA2) homologues are highly myotoxic
proteins which, although lacking catalytic activity, possess the ability to disrupt
biological membranes, inducing significant muscle-tissue loss and permanent
disability in severely envenomed patients. Since the structural basis for their
toxic activity is still only partially understood, the structure of myotoxin II, a
monomeric Lys49 PLA2 homologue from Atropoides nummifer, has been
determined at 2.08 A˚ resolution and the anion-binding site has been
characterized.
1. Introduction
Skeletal muscle necrosis is a frequent consequence of envenomation
by snakes of the family Crotalidae and may lead to significant tissue
loss and permanent disability (Mebs & Ownby, 1990; Nishioka &
Silveira, 1992). The venoms of these snakes contain a number of basic
phospholipases A2 (PLA2s; EC 3.1.1.4) that play prominent roles in
the pathogenesis of myonecrosis (Gutie´rrez & Lomonte, 1995). These
myotoxic proteins are classified as belonging to the group IIA PLA2s
on the basis of their primary structure and disulfide-bonding pattern
(Six & Dennis, 2000). A subgroup of catalytically inactive variants or
PLA2 homologues was initially characterized from the venom of the
North American water mocassin Agkistrodon piscivorus piscivorus,
in which the conserved Asp at position 49 is replaced by Lys
(Maraganore et al., 1984; Scott et al., 1992; Arni & Ward, 1996).
Homologous ‘Lys49 PLA2 myotoxins’ have now been encountered in
the venoms of a wide variety of crotalid species (reviewed by
Lomonte et al., 2003) and have attracted attention since they serve as
models for the investigation of the structural basis of the catalytically
independent mechanisms of membrane damage. Recently, it has been
demonstrated that these basic Lys49 PLA2s bind to the extracellular
domain of the vascular endothelial growth factor (VEGF165) receptor
with a sub-nanomolar affinity (Yamazaki et al., 2005).
Two Lys49 PLA2 homologues have previously been isolated from
the venom ofAtropoides nummifer, a crotalid snake distributed along
the Central American isthmus (Taylor et al., 1974; Solo´rzano, 1989).
A. nummifer myotoxin I (Gutie´rrez et al., 1986) has been crystallized
and its structure has been reported at 2.4 A˚ resolution (Arni &
Gutie´rrez, 1993; de Azevedo et al., 1999); however, since its amino-
acid sequence has not been determined, accurate structural data is as
yet unavailable. On the other hand, A. nummifer myotoxin II
(Anum-II) has been well characterized in terms of its biological
activities (Angulo et al., 2000) and its complete amino-acid sequence
has been determined (SwissProt code P82950; Angulo et al., 2002).
This protein has recently been crystallized (Watanabe et al., 2004) and
the present report presents a detailed analysis of its three-
dimensional structure, which has been determined at 2.08 A˚
resolution.
2. Materials and methods
2.1. Purification, crystallization and data collection
A. nummifer venom was obtained from more than 15 specimens
collected in Costa Rica. Anum-II was purified by cation-exchange
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chromatography on carboxymethyl-Sephadex C-25 (Pharmacia)
(Angulo et al., 2000) and reverse-phase high-performance liquid
chromatography (RP-HPLC) on a C4 column (Vydac) which was
eluted at a flow rate of 1.0 ml min1 with a gradient ranging from 0 to
60% acetonitrile in 0.1% trifluoroacetic acid, using a Waters 600E
instrument (Watanabe et al., 2004).
The Anum-II sample was dissolved in water at a concentration of
10 mg ml1. Crystallization experiments were carried out by the
hanging-drop vapour-diffusion method. Single crystals were obtained
when a 2 ml protein droplet was mixed with an equal volume of a
solution consisting of 0.1M sodium acetate pH 4.6, 20% PEG 3350
and 0.2M ammonium sulfate and subsequently equilibrated over
1 ml of the latter solution at 291 K (Watanabe et al., 2004). Crystals of
Anum-II were flash-cooled in crystallization solution to which
15%(v/v) glycerol had been added. Diffraction data were collected
from a single cryoprotected Anum-II crystal utilizing a wavelength of
1.427 A˚ (at 100 K) at a synchrotron-radiation source (Laborato´rio
Nacional de Luz Sı´ncrotron, Campinas, Brazil). Intensity data were
reduced and processed at 2.08 A˚ using the program MOSFLM
(Leslie, 1992). The crystals of Anum-II belong to space group P43212
and are compatible with the presence of one protein molecule in the
asymmetric unit. The data-collection and processing statistics are
summarized in Table 1.
2.2. Structure determination and crystallographic refinement
The crystal structure of Anum-II was determined by molecular
replacement using the program MOLREP (Vagin & Teplyakov,
1997). The atomic coordinates of a Lys49 PLA2 isolated from the
venom ofAg. acutus (PDB code 1mc2), stripped of solvent and ligand
atoms, were used to generate the search model. The cross-rotation
and translation functions were calculated over the resolution range
20.0–3.0 A˚ and the rotation angles which produced the peak with the
highest correlation and the lowest R factor were applied to the search
model for the translation search. The searches were performed for
both enantiomorphic space groups (P43212 and P41212) and the
correct solution was selected based on the crystallographic residual
and the correlation coefficient. The model was subjected to isotropic
restrained refinement using the program REFMAC5 (Murshudov et
al., 1997) and the structural model was improved based on 2Fo  Fc
and Fo  Fc electron-density maps, which were examined using the
graphics program TURBO-FRODO (Roussel & Cambillau, 1991).
During the refinement, residual density observed near Arg34 was
attributed to a sulfate ion based on the tetrahedral shape of the
density and the possible interactions. The refinement converged to an
R factor of 22% and an Rfree of 27% (Table 1).
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Table 1
Data-collection and refinement statistics of the Anum-II crystal structure.
Values in parentheses are for the highest resolution shell.
Data collection
Space group P43212
Unit-cell parameters (A˚) a = b = 68.94, c = 64.07
VM (A˚
3 Da1) 2.66
Solvent content (%) 53.40
Resolution range (A˚) 30.36–2.08 (2.19–2.08)
No. of unique reflections 9671
Completeness (%) 99.3 (94.1)
Rmerge† (%) 8.9 (48.1)
I/(I) 6.7 (2.3)
Refinement
R factor‡ (%) 21.9
Rfree§ (%) 27.0
B values} (A˚2)
Overall 30.48
Main chain 28.64
Side chain 29.2
R.m.s.d. in bond length (A˚) 0.021
R.m.s.d. in bond angles () 1.868
† Rmerge = 100 
P½P jIðhÞ  hIðhÞij=P IðhÞ, where I(h) is the observed intensity and
hI(h)i is the mean intensity of reflection h over all measurements of I(h). ‡ R factor =
100  PðjFo  FcjÞ=
PðFoÞ, the sums being taken over all reflections with F/(F) > 2
cutoff. § Rfree = R factor for 5% of the data which were not included during
crystallographic refinement. } B values are average B values for all non-H atoms.
Figure 1
Cartoon representation of the A. nummifer myotoxin II (Anum-II) crystal
structure. The residues which form the nominal active-site are presented in atom
colours. CBL: putative calcium-binding loop.
Figure 2
Superpositioning of Anum-II on the structures of B. godmani (PDB code 1god),
B. asper (1clp, chain A), Ag. piscivorus piscivorus (1ppa), B. pirajai (1qll) and
Ag. acutus (1mc2) Lys49 PLA2s. The structural differences are highighted by
utilizing different colours.
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3. Results and discussion
3.1. Overall structure
The asymmetric unit of the Anum-II crystals consists of one
protein molecule (121 amino-acid residues), one sulfate ion and 71
solvent water molecules. The quality of the model assessed by
PROCHECK (Laskowski et al., 1993) indicates that the stereo-
chemical parameters lie within the expected range and the overall
deviations from ideal stereochemistry are presented in Table 1. The
Ramachandran diagram (Ramachandran et al., 1963) indicates that
87% of the main-chain dihedral angles of all non-glycine and non-
proline residues are located in the energetically most favoured
regions, 12% are located in the additional permitted regions and only
1% lie in the generously permitted region. Based on the nomen-
clature and numbering scheme suggested by Renetseder et al. (1985),
Anum-II can be classified as a class II PLA2 enzyme and is stabilized
by seven disulfide bridges (between residues 27 and 125, 29 and 45, 44
and 105, 50 and 133, 51 and 98, 61 and 91, and 84 and 96). The
structures of PLA2s have been extensively reviewed (Arni & Ward,
1996); briefly, the Anum-II structure can be considered to be formed
of a short N-terminal -helix (residues 2–12), a putative Ca2+-binding
loop (residues 25–35), a second -helix (residues 40–55), a two-
stranded antiparallel sheet referred to as the -wing (residues 74–85)
and a third -helix (residues 90–107) that is antiparallel to the second;
these two long helices are linked by two disulfide bridges to form a
rigid platform. The positions of the amino-acid residues that form the
catalytic apparatus (His48, Tyr52, Tyr73 and Asp99, including the
catalytic water molecule) are conserved except for Asp49, which is
substituted by Lys (Fig. 1). Superpositioning the Anum-II structure
onto the structures of other Lys49 PLA2s indicates that all structural
features are conserved, with inherent flexibility observed in the
C-terminus, putative calcium-binding loop, -wing connecting loop
and the tip of the -wing (Fig. 2).
3.2. Anion-binding site
Clear density for a tetrahedral molecule was observed close to
Arg34 in both the 2Fo  Fc and Fo  Fc electron-density maps. Since
the mother solution contains 0.2M ammonium sulfate, this electron
density was considered to represent a sulfate ion based on the
geometry and possible hydrogen bonds. In this model, the O1 atom of
the sulfate ion is anchored by hydrogen bonds to Arg34 N" (2.90 A˚),
Lys53 N (3.13 A˚) and a solvent water molecule (2.45 A˚). The O2
atom interacts with the main-chain NH group of Arg34 (3.02 A˚) and
the O4 atom with Lys53 N (3.38 A˚) and Arg34 N2 (2.68 A˚) (Fig. 3).
The crystal structure of Ag. contortrix laticinctus myotoxin also
indicated the presence of a sulfate ion bound to Arg34 and Lys53
(Ambrosio et al., 2005) and the sulfonyl group of the suramin
molecule was shown to interact with Arg34 in Bothrops asper
myotoxin II (Murakami et al., 2005). This indicates that Arg34, which
is strictly conserved in all Lys49 PLA2s (Fig. 4), is likely to play a
crucial role in the binding of negatively charged substrates or inhi-
bitors.
3.3. Oligomeric state
The dimerization of Lys49 PLA2s has been suggested to play an
important role in their ability to damage membranes (de Oliveira et
al., 2001) and in the expression of cytolytic and myotoxic activities
(Angulo et al., 2005). Previous crystallographic results on the Lys49
PLA2s B. asper myotoxin II (Arni et al., 1995), B. pirajai piratoxin I
(de Azevedo et al., 1998) and B. jararacussu bothropstoxin I (Giotto
et al., 1998) suggested that the monomers present in the asymmetric
unit are related by a twofold axis and that the dimer is stabilized by
reciprocal interactions formed at the interface of the N-terminal and
-wing regions that encompass the conserved interfacial residues
Glu12, Trp77 and Lys80 (Ward et al., 1998; Ruller et al., 2005). This
quaternary arrangement stabilized by the Glu12–Lys80 salt bridge
has been considered to represent the biologically relevant form
(Ward et al., 1998) and has been shown to be very stable.
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Figure 3
Interactions of the sulfate ion with Arg34 and Lys53 of Anum-II.
Figure 4
Sequence alignment of Anum-II with other Lys49 PLA2s from Cerrophidion (Bothrops) godmani (PDB code 1god), B. asper (1clp), Ag. piscivorus piscivorus (1ppa),
B. pirajai (1qll, chain A) and Ag. acutus (1mc2).
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However, a Lys49 PLA2 from Deinagkistrodon acutus (PDB code
1mg6; Huang et al., unpublished work), myotoxin from Ag. contortrix
laticinctus (PDB code 1s8g; Ambrosio et al., 2005), myotoxin II from
Cerrophidion (Bothrops) godmani (Arni et al., 1999) and Anum-II
(this work) exist as monomers in the crystalline state. Anum-II is
present as a dimer in solution at physiological pH (Angulo et al.,
2000). Thus, the monomeric Anum II observed in the asymmetric unit
may be an artifact of the crystallization process and the low pH of the
solution (pH 5). In the case of bothropstoxin I (BthTX-I), the effect
of pH on the monomer–dimer equilibrium was examined based on
the fluorescent properties of the single Trp77 and it was shown that
the monomeric form of the protein is predominant at acidic pH
(de Oliveira et al., 2001). Small-angle X-ray scattering studies
currently in progress will be useful in clarifying the parameters that
influence the equilibrium between monomers and dimers.
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